Evolus, Inc. (EOLS)
NASDAQ · Manufacturing · Pharmaceutical preparations
EOLS price, last 12 months
Key stats
- Previous close
- $7.86
- Open
- $7.84
- Day range
- $7.71 – $8.00
- 52-week range
- $3.86 – $9.31
- Volume
- 398.3K
- Avg volume (20 days)
- 787.5K
- Market cap
- $526.4M
Performance
Technicals and fundamentals
About Evolus, Inc.
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $526.4M